Advertisement
UK markets closed
  • NIKKEI 225

    39,667.07
    +493.92 (+1.26%)
     
  • HANG SENG

    18,089.93
    +17.03 (+0.09%)
     
  • CRUDE OIL

    80.74
    -0.09 (-0.11%)
     
  • GOLD FUTURES

    2,309.60
    -21.20 (-0.91%)
     
  • DOW

    39,135.66
    +23.50 (+0.06%)
     
  • Bitcoin GBP

    48,180.57
    -925.16 (-1.88%)
     
  • CMC Crypto 200

    1,263.91
    -19.88 (-1.55%)
     
  • NASDAQ Composite

    17,756.08
    +38.42 (+0.22%)
     
  • UK FTSE All Share

    4,480.66
    -12.41 (-0.28%)
     

Intra-Cellular Therapies Eyes $1.7 Billion Opportunity After Phase 3 Win

Intra-Cellular Therapies Eyes $1.7 Billion Opportunity After Phase 3 Win

Intra-Cellular has a big opportunity in depression treatment, an analyst said Tuesday as the biotech stock surged on test results.